Appointment of Joint Corporate Broker

RNS Number : 1926N

Syncona Limited

16 January 2019

 

 16 January 2019

Syncona Limited ("Syncona")

Appointment of Joint Corporate Broker

Syncona is pleased to announce that it has appointed Goldman Sachs International with immediate effect as joint Corporate Broker alongside Numis Securities, who remain joint Corporate Broker.

END

Enquiries:

Investor enquiries
Annabel Clay   Tel: [phone]
Goldman Sachs	Numis Securities
Charlie Lytle Tom Hartley Lucy Clarke Tel: [phone]	Nathan Brown James Black Freddie Barnfield Tel: [phone]

About Syncona

Syncona is a leading FTSE250 healthcare company focused on founding, building and funding global leaders in life science. Our vision is to deliver transformational treatments to patients in truly innovative areas of healthcare while generating superior returns for shareholders.

We seek to partner with the best, brightest and most ambitious minds in science to build globally competitive businesses.

We take a long-term view, underpinned by a deep pool of capital, and are established leaders in gene and cell therapy. We focus on delivering dramatic efficacy for patients in areas of high unmet need.

 

END

 

 

APPCKPDKCBKDCDD